Edgewise Therapeutics, Inc.
2021 Q4 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 912 | 0.0% | 36,759 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 502 | 0.0% | 38,328 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,254 | 0.0% | 56,988 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,073 | 0.0% | 40,170 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,025 | 0.0% | 38,410 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 691 | 0.0% | 38,366 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 558 | 0.0% | 30,580 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 189 | 0.0% | 17,258 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 103 | 0.0% | 17,920 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 137 | 0.0% | 17,728 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 96 | 0.0% | 14,434 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 129 | 0.0% | 14,434 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 124 | 0.0% | 12,607 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 104 | 0.0% | 13,017 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 153 | 0.0% | 15,730 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 289 | 0.0% | 18,934 | 12/31/2021 |